For generations, treating cancer has relied on a pretty brutal calculus: hit the body hard and hope the cancer dies first. Traditional chemotherapy is essentially a scorched-earth strategy. It works, but at a massive cost—wrecking the heart, gut, and nervous system along with the tumour. . For decades, researchers have chased a deceptively simple question: What if we could send the drug only where it’s actually needed? Antibody-drug conjugates, or ADCs, are the most promising

Fractional vs Interim in Life Sciences – Not the Same Thing I’m seeing more life sciences organisations explore fractional senior roles – and they’re often confused with interim roles. Interim: usually full‑time, time‑limited, covering a defined role for a fixed period. Fractional: usually part‑time, longer-term, adding senior expertise for a set number of days or hours without owning the whole role. In a milestone‑driven, resource‑constrained environment, fractional models

For decades, psychiatric drug development has operated with a deceptively simple story. Mental illness lives in the brain. Depression is a serotonin problem. Drug development followed that logic. That story isn’t exactly wrong. But it is increasingly incomplete. What if depression isn’t primarily a brain disorder - but a network disorder?